top of page
Insights That Move the GPCR Field Forward
Read the latest analyses, interviews, and discoveries shaping the GPCR ecosystem — from research breakthroughs to biotech strategy.
GPCR News powered by our Strategic Partners
Blog: Blog2
Search
GPCR Papers
GPCR Papers features curated selections of cutting-edge research advancing receptor biology, pharmacology, and therapeutic innovation. Each post highlights the studies shaping our understanding of GPCRs and their impact across discovery and translational science.
Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
March 2022 "March 3, 2022 Susanna Naggie, MD, and Sudarshan Rajagopal, MD, PhD Two School of Medicine faculty members — Susanna Naggie,...
GPCR News
Feb 28, 20221 min read
Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
March 2022 Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief Commercial Officer "SAN DIEGO –...
GPCR News
Feb 28, 20221 min read
Ermium Therapeutics has constituted its SAB
February 2022 "Ermium Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs...
GPCR News
Jan 31, 20221 min read
AELIS PHARMA launches their IPO for €25 million
February 2022 "We are proud to announce the success of our IPO! Thank you to our shareholders, both historical and new, for their trust....
GPCR News
Jan 31, 20221 min read
InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
February 2022 "InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating to unlock orphan targets leveraging...
GPCR News
Jan 31, 20221 min read
Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical...
GPCR News
Jan 31, 20221 min read
Carola Weiss joins InterAx Biotech AG as VP Business Development
February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined the company as VP Business...
GPCR News
Jan 31, 20221 min read
Sosei Heptares reported its FY2021 financial result and provided an update on operational activities
February 2022 Read more at the source #DrGPCR #GPCR #IndustryNews
GPCR News
Jan 31, 20221 min read
Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder "Jan 27,...
GPCR News
Jan 31, 20221 min read
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
January 2022 Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered...
GPCR News
Jan 1, 20221 min read
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
January 2022 "Watch our CEO Tim Dyer on AlphaStreet. In his interview, Mr. Dyer provides an overview of our #allostericmodulator...
GPCR News
Jan 1, 20221 min read
Novo Nordisk moves to strengthen obesity efforts
January 2022 "After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position in the obesity space through a...
GPCR News
Jan 1, 20221 min read
ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
January 2022 ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis "SAN CARLOS,...
GPCR News
Jan 1, 20221 min read
Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...
GPCR News
Jan 1, 20221 min read
Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers have discovered the vast...
GPCR News
Jan 1, 20221 min read
ShouTi Pharma has a brand new website
January 2022 "We are an experienced, innovative, global team on a bold mission to improve health by creating and developing life-changing...
GPCR News
Jan 1, 20221 min read
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
January 2022 Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update...
GPCR News
Jan 1, 20221 min read
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
January 2022 "OXFORD, England--Professor Charlotte Deane, Ph.D., of the University of Oxford, has joined Exscientia as Chief Scientist of...
GPCR News
Jan 1, 20221 min read
Drug Discovery Picks Up the Pace, Stays on Target
January 2022 "Voltaire argued, “Perfection is attained by slow degrees; it requires the hand of time.” However, in drug discovery...
GPCR News
Jan 1, 20221 min read
Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...
GPCR News
Dec 31, 20211 min read
A role for BET proteins in regulating basal, dopamine-induced and cAMP/PKA-dependent ...
A role for BET proteins in regulating basal, dopamine-induced and cAMP/PKA-dependent transcription in rat striatal neurons The activity...
GPCR News
Dec 31, 20211 min read
Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4 WHIM...
GPCR News
Dec 29, 20211 min read
Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of hereditary degenerative diseases affecting 1 of 4000 people worldwide and being the most...
GPCR News
Dec 29, 20211 min read
Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
"Protecting neurons from death during oxidative and neuroexcitotoxic stress is key for preventing cognitive dysfunction. We uncovered a...
GPCR News
Dec 29, 20211 min read
bottom of page